Prologue Medicines Funding: $50M Raised, Series A (2024)
Prologue Medicines is a Biotech company based in Cambridge, Massachusetts. It has raised $50M in total funding. Latest round: Series A.
Prologue Medicines funding overview
Prologue Medicines is a Biotech company based in Cambridge, Massachusetts. Prologue Medicines has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2024. The round record for Prologue Medicines runs through 2024; nothing later has been disclosed. Investors on record include Flagship Pioneering.
Prologue Medicines at a glance
Total raised
$50M
Latest round
Series A
Latest round date
May 2024
Industry
Biotech
Headquarters
Cambridge, Massachusetts
Notable investors
Flagship Pioneering
Frequently asked about Prologue Medicines funding
How much has Prologue Medicines raised?
Prologue Medicines has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Prologue Medicines?
Flagship Pioneering are named among the investors backing Prologue Medicines.
What was the latest Prologue Medicines funding round?
The most recent disclosed round is a Series A, announced in May 2024.
Where is Prologue Medicines based?
Prologue Medicines is based in Cambridge, Massachusetts.
What sector does Prologue Medicines operate in?
Prologue Medicines is tracked under Biotech from Cambridge, Massachusetts, with $50M in disclosed funding.
When did Prologue Medicines last raise?
The last disclosed Prologue Medicines round closed in May 2024 at Series A.
Totals shown for Prologue Medicines aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Cambridge and the investors behind them below.
